Valeant Pharmaceuticals: Intrigued…Really?

Deutsche Bank analyst Gregg Gilbert is warming up the the controversial drug maker. Here's why.....»»

Category: blogSource: barronsMay 19th, 2017

Eyegate Pharma stock surges 11% after receiving Valeant milestone payment

Eyegate Pharmaceuticals Inc. stock surged 11% in premarket trade Monday after the company said it had received its fir.....»»

Category: topSource: marketwatch9 hr. 0 min. ago

Valeant Pharmaceuticals: Intrigued…Really?

Deutsche Bank analyst Gregg Gilbert is warming up the the controversial drug maker. Here's why.....»»

Category: blogSource: barronsMay 19th, 2017

Valeant (VRX) Decides to Extend Stay on Xifaxan"s ANDA

Valeant Pharmaceuticals International, Inc. (VRX) announced that it has decided to stay outstanding litigation and extend the 30-month stay regarding Teva's ANDA for a generic version of Xifaxan 550 mg tablets. Valeant Pharma.....»»

Category: topSource: zacksMay 19th, 2017

Valeant Stock Is Slowly Becoming Bullish Once Again

VRX Stock: Staging an Advance Putting hard-earned dollars into an investment like Valeant Pharmaceuticals Intl Inc (NYSE:VRX) stock isn'.....»»

Category: analysisSource: profitconfidentialMay 17th, 2017

Valeant and Actavis agree to stay litigation relating to Valeant"s top-selling drug Xifaxan

Salix Pharmaceuticals Inc. and its parent Valeant.....»»

Category: topSource: marketwatchMay 17th, 2017

Why Valeant Pharmaceuticals Intl Inc (VRX) Stock Is Still Ugly As Ever

InvestorPlace - Stock Market News, Sto.....»»

Category: topSource: investorplaceMay 16th, 2017

Teva (TEVA) Launches Glumetza Generic, Inks Deal with Otsuka

Teva Pharmaceutical Industries Ltd. (TEVA) announced the launch of a generic version of Valeant Pharmaceuticals International, Inc.'s (VRX) diabetes drug, Glumetza, in the U.S. Teva .....»»

Category: topSource: zacksMay 16th, 2017

Jeff Ubben Buys Bioverativ Inc, Valeant Pharmaceuticals International Inc, NetScout Systems ...

Related Stocks: VRX, NTCT, BIVV, ALSN,.....»»

Category: worldSource: nytMay 15th, 2017

Valeant Pharmaceuticals: Why One Bear is Staying Bearish

Bronte Capital's John Hempton explains why he's not jumping on the Valeant Pharmaceuticals train......»»

Category: blogSource: barronsMay 15th, 2017

Valeant Pharmaceuticals: Living to Fight Another Day?

Barclays analysts note that Valeant's earnings weren't as bad as expected, but that it needs to "provide road map" to reducing its leverage......»»

Category: blogSource: barronsMay 12th, 2017

Jim Cramer Weighs In On Valeant, Corning And Synergy Pharmaceuticals

Jim Cramer spoke on CNBC's Mad Money about Valeant Pharmaceuticals Intl Inc (NYSE: VRX). He thinks the company should do an equity offering to reduce its huge debt. read more.....»»

Category: blogSource: benzingaMay 12th, 2017

Valeant Pharmaceuticals: The Bear is Back in Town

Wells Fargo's David Maris that Valeant's leverage ratio is increasing even after the specialty pharmaceutical company raised its guidance......»»

Category: blogSource: barronsMay 11th, 2017

Valeant stock jumps 8% after positive patent litigation developments

Valeant Pharmaceuticals International.....»»

Category: topSource: marketwatchMay 11th, 2017

Go Long Valeant Pharmaceuticals Intl Inc (VRX) Stock for Free

InvestorPlace - Stock Market News, .....»»

Category: topSource: investorplaceMay 11th, 2017

Valeant Pharmaceuticals: Feeling Sentimental?

Valeant is trying to gain for a third day in a row. Has sentiment towards the stock changed?.....»»

Category: blogSource: barronsMay 11th, 2017

Valeant (VRX) Q1 Earnings & Revenues Miss, View Raised

Shares of Valeant Pharmaceuticals Inc. (VRX) surged significantly after the company raised the annual guidance for 2017 concurrent with the first-quarter 2017 earnings. Shares of Valeant Pharmaceuticals In.....»»

Category: topSource: zacksMay 10th, 2017

Wednesday’s Vital Data: Nvidia Corporation (NVDA), Walt Disney Co (DIS) and Valeant Pharmaceuticals Intl Inc (VRX)

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Nvidia (NVDA) options bears c.....»»

Category: topSource: investorplaceMay 10th, 2017

Valeant Expresses Confidence In Outlook, But Might Be Too Early To Get Bullish

The latest chapter in the Valeant Pharmaceuticals Intl Inc (NYSE: VRX) drama is a happy one. Latest Ratings for .....»»

Category: blogSource: benzingaMay 10th, 2017

Valeant Pharmaceuticals: The End of the Beginning?

Shares of Valeant continue to rise a day after gaining more than 20%......»»

Category: blogSource: barronsMay 10th, 2017

Valeant Pharmaceuticals" Q1 Report Might Be the Greatest Smoke-and-Mirrors Show You"ll Ever See

Dig beneath the headlines and you'll see a company that made very few improvements during the first quarter......»»

Category: topSource: foxnewsMay 10th, 2017